Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Fentanyl
Ferrous sulfate
Fibrinogen concentrate C.10. If this patient had a massive blood loss, what blood replacement therapy would be indicated? C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.6. What are the options to treat acquired hypofibrinogenemia? C.9. Two hours later, estimated blood loss (EBL) is approximately 2 L and the patient has been resuscitated with 3 units of packed red blood cells (pRBCs), 229 mL intraoperative cell salvage (cell saver), and 500 mL albumin in addition to 4 L crystalloid. The surgeon says the field is still "oozy" and there is ongoing blood loss. What are your concerns for resuscitation moving forward? How will you guide your resuscitation? D.3. Describe the pathophysiology of potential complications following massive transfusion and hematologic resuscitation. What are the risks of thromboembolic complications after intraoperative administration of procoagulants?
Fletcher D.2. When will you wean the patient from the ventilator? D.3. What are the advantages and disadvantages of early tracheal extubation?
Fludrocortisone
Flumazenil C.16. What is your approach to emergence? What if the patient does not regain consciousness? C.3. How does the liver disease affect intraoperative medication management?
Fluoride A.5. If succinylcholine were the only NMBA used during the case and the patient did not exhibit a response to TOF stimulation, what is the likely diagnosis? How would you confirm it? C.6. How would you maintain anesthesia during the case?
Fluoxetine
Flurbiprofen
Fluvastatin
Folate
Furosemide
Ganciclovir
Gentamicin
Glimepiride
Glyburide
Growth hormone
Guanethidine
Haloperidol A.12. What is neuroleptic malignant syndrome (NMS)? What is serotonin syndrome? C.8. What components of ERAS are applied in the intraoperative phase of the care of patients undergoing CRS? D.1. The patient is extremely agitated upon emergence. Discuss the risk factors for postictal agitation (PIA) as well as the therapeutic options.
Hemabate
Heparin
Hetastarch B.5. What are the principal disadvantages associated with the common posterior fossa craniotomy positions? C.4. Why are hypertonic fluids used during a craniotomy?
Hyaluronidase
Hydralazine A.14. What is the mechanism of action of the major antihypertensive drugs? A.5. What is autoregulation, and why is it important? B.4. What is the preoperative management of a patient presenting with an acute aortic dissection (AAD)? B.5. Are you concerned about this patient's blood pressure and heart rate? What treatment would you institute? B.5. What are the goals and agents of choice for severe hypertension seen with preeclampsia? C.10. During the surgery, the blood pressure increases to 220/120 mm Hg. How would you treat the hypertension? D.1. What are the major concerns following craniotomy? D.2. Postoperatively, the patient's blood pressure is 170/96 mm Hg. Will you treat this? E.6. What are the significant implications of the denervated heart?
Hydrochlorothiazide C.10. If this patient had a massive blood loss, what blood replacement therapy would be indicated? C.2. How will the surgical considerations affect your anesthetic plan for this patient? C.8. If this patient had ongoing bleeding intraoperatively, what guidelines help determine when red blood cell (RBC) transfusions should be given? C.8. Point-of-care testing at the start of the posterior portion of the case reveals a hemoglobin and hematocrit (Hb/Hct) of 11.1/33. Two hours into the posterior portion, Hb/Hct is 7.8/23. Would you transfuse? What are your thresholds for blood transfusion? C.9. What laboratory tests should be ordered during the resuscitation of this patient? D.4. What strategies can be used to minimize the risk of postoperative visual loss (POVL)? Major and Complex Spine Surgery Placenta Previa/Placenta Accreta Spectrum
Hydrocodone B.14. Describe the different routes of opioid administration. D.4. How is postoperative pain treated?
Hydrocortisone B.15. The patient was on 20 mg of prednisone per day for 5 days as part of the treatment of an asthma exacerbation 3 months ago. He is currently not on corticosteroids. Should the patient receive "stress-dose" corticosteroids? C.2. How would you induce and maintain anesthesia? D.8. What treatments can be undertaken once a diagnosis of cerebral vasospasm is made? D.9. What are other neurologic complications following SAH and aneurysm clipping?
Hydromorphone A.10. What is the usual clinical regimen for intravenous patient-controlled analgesia (IV-PCA) and is special patient monitoring required during its use? A.6. Does the choice of drugs influence the efficacy or safety of epidural analgesia? A.7. What are the usual doses and concentrations of the anesthetic combinations commonly employed in epidural analgesia? B.14. Describe the different routes of opioid administration. B.3. What are the management strategies for perioperative pain control in a patient taking buprenorphine for OUD? B.3. What premedication would you order? Brachial Plexus Block C.5. Which medications can be used intrathecally? What is ziconotide? D.3. How would you control postoperative pain? What are the alternatives in the management of this patient's postoperative pain? D.6. How would you control postoperative pain? What are the sources of surgical pain? What is the role of regional anesthesia in the bariatric surgery?
Hydroxocobalamin
Hydroxyurea A.5. What are the clinical features of sickle cell disease? Sickle Cell Disease